- Qatar-based healthtech startup iQtech has closed its first investment round with backing from European assessment technology firm Selexi and deep-tech partner Yuniro to advance its XR-based (extended reality-based) medical simulation platform.
- Founded in 2025 by Nassim Davide Sidaoui, the company is developing EsculapioVR, an AI-powered training and assessment platform that combines immersive virtual reality simulations with AI-driven evaluation tools to modernise medical education.
- The funding will be used to accelerate product development, strengthen technical infrastructure, and expand deployments across Qatar and the wider MENA region, with applications spanning healthcare, civil training, and military sectors.
Press release:
iQtech LLC, a Qatar-based startup specialising in advanced medical simulation and cross-reality (XR) technologies, has announced the successful close of its first investment round.
The round includes backing from European assessment technology leader Selexi and deep-tech collaborator Yuniro. The funding marks a key milestone for the startup, founded in 2025, as it transitions from its founding phase into a structured growth stage.
The investment will support the development of EsculapioVR, iQtech’s flagship AI-powered medical training and assessment platform. The system combines immersive virtual reality simulations with AI-driven performance evaluation to enhance medical education and training outcomes.
Operating from Doha within the Qatar Science & Technology Park (QSTP) ecosystem, iQtech is positioning itself at the intersection of healthtech and edutech. The company aims to modernise professional training by enabling high-fidelity simulations for healthcare professionals as well as civil and military training environments.
With the new funding, iQtech plans to strengthen its technical infrastructure, accelerate platform development, and expand deployments across Qatar and the wider MENA region.